Abstract:Several important factors for sensitive detection of small peptide drugs in human urine by SPE and UPLC‐HRMS were investigated. The results showed that full scan combined with PRM mode could effectively realize the sensitive detection of small peptides, and the addition of protein precipitants would adversely affect the detection of certain analytes. In addition, the addition of ammonium formate into reverse UPLC mobile phase would alter the charge state distribution of small peptides. Small peptide hormones are widely used in sports as performance‐enhancing substances, making it crucial to develop sensitive analytical methods for their detection in doping control analysis. Various factors significantly affect analytical sensitivity, such as the selection of ultra‐performance liquid chromatography (UPLC) mobile phase, high‐resolution mass spectrometry (HRMS) scanning modes, and extraction solvents for pretreatment. Herein, comparative study approach was utilized to investigate the sensitivity of each peptide analyte under both full scan and parallel reaction monitoring (PRM) modes of HRMS and assess the effects of some protein precipitants as a part of extraction solvents on solid‐phase extraction (SPE). The results showed that full scan should be selected as the primary scan mode of HRMS, and the combination with PRM mode could effectively compensate for the limitations of full scan, and the addition of protein precipitants would adversely affect the detection of certain small peptide analytes. Meanwhile, influences of ammonium formate in reverse UPLC mobile phase on the charge state distribution of small peptides were investigated and elucidated. Based on these findings, a sensitive and reliable UPLC‐HRMS analytical method combining full scan and PRM mode was validated for screening and confirmation of 63 small peptide analytes after SPE, with limits of detection (LODs) ranging between 0.010 and 0.473 ng/ml and limits of identification (LOIs) ranging between 0.015 and 1.512 ng/ml. Additionally, suggestions were provided for the detection of [Arg8]‐vasopressin, dermorphin, and its analogues.

Elucidating important factors and corresponding method optimization for sensitive detection of small peptide drugs in human urine by solid‐phase extraction and UPLC‐HRMS: The influence of MS scan modes, protein precipitants, and ammonium formate

Doping Control Analysis of Small Peptides in Human Urine Using LC-HRMS with Parallel Reaction Monitoring Mode: Screening and Confirmation.

Multi-analyte screening of small peptides by alkaline pre-activated solid phase extraction coupled with liquid chromatography-high resolution mass spectrometry in doping controls

The sensitive detection of low molecular mass peptide drugs in dried blood spots by solid-phase extraction and LC-HRMS

Analysis of Peptides in Plasma by High Performance Liquid Chromatography Coupled with Electrospray Ionization Mass Spectrometry

An Automatic Online Solid-Phase Dehydrate Extraction-Ultra-high Performance Supercritical Fluid Chromatography-Tandem Mass Spectrometry System Using a Dilution Strategy for the Screening of Doping Agents in Human Urine.

Detection of Nine WADA Prohibited GHRPs and GHS Using the HPLC-MS/MS Method and Their Stability in Human Urine

Chromatographic–mass spectrometric analysis of peptidic analytes (2–10 kDa) in doping control urine samples

A Sensitive Dilute-and-Shoot Approach for the Simultaneous Screening of 71 Stimulants and 7 Metabolites in Human Urine by LC-MS-MS with Dynamic MRM.

Rapid Determination of 15 Β 2 -Agonists Residues in Swine Urine by Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry Coupled with Molecularly Imprinted Solid Phase Extraction

Simultaneous Analysis of Fourteen Tertiary Amine Stimulants in Human Urine for Doping Control Purposes by Liquid Chromatography-Tandem Mass Spectrometry and Gas Chromatography-Mass Spectrometry

A New Method for the Analysis of Beta(2)-Agonists in Human Urine by Pressure-Assisted Capillary Electrochromatography Coupled with Electrospray Ionization-Mass Spectrometry Using a Silica-Based Monolithic Column.

A Broad-Spectrum Peptide Screening Method Using an Optimized Solid-Phase Extraction and Liquid Chromatography–High-Field Asymmetric Ion Mobility Spectrometry–Mass Spectrometry for Doping Control in Equine Urine

Rapid Determination Of 15 Beta(2)-Agonists Residues In Swine Urine By Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry Coupled With Molecularly Imprinted Solid Phase Extraction

Analysis of Β-Agonists and Β-Blockers in Urine Using Hollow Fibre-Protected Liquid-Phase Microextraction with in Situ Derivatization Followed by Gas Chromatography/mass Spectrometry

Simultaneous determination of amino acids, purines and derivatives in serum by UHPLC/MS/MS.

Accurate Quantification of EVT201 and Its Two Metabolites in Human Urine Using UHPLC-MS/MS Method with Solid Phase Extraction

Polymer Monolith Microextraction Online Coupled to Hydrophilic Interaction Chromatography/Mass Spectrometry for Analysis of Beta(2)-Agonist in Human Urine

Method Development and Validation for Simultaneous Detection of Corticosteroids, Small Peptides, SARMs and Quaternary Ammonium Drugs in Camel Urine for Doping Control Applications

Rapid and Sensitive Determination of Nine Bisphenol Analogues, Three Amphenicol Antibiotics, and Six Phthalate Metabolites in Human Urine Samples Using UHPLC-MS/MS

Rapid On-Site Detection of Illicit Drugs in Urine Using C18 Pipette-Tip Based Solid-Phase Extraction Coupled with a Miniaturized Mass Spectrometer